Colorectal cancer: Liquid biopsy enables real-time monitoring of molecular alterations in CRC

Nature Reviews Gastroenterology and Hepatology

Volumn 12, Issue 7, 2015, Pages 372-

  Ray, Katrina ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CIRCULATING TUMOR DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; PANITUMUMAB; UNCLASSIFIED DRUG;

BIOPSY TECHNIQUE; CANCER PROGNOSIS; COLORECTAL CANCER; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENE MUTATION; GENOME ANALYSIS; HUMAN; LIQUID BIOPSY; NOTE; ONCOGENE K RAS; ONCOGENE N RAS; PATIENT MONITORING; PHARMACOGENOMICS; PRIORITY JOURNAL; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; BLOOD; CLONAL EVOLUTION; COLORECTAL TUMOR; DRUG RESISTANCE; GENETICS;

CLONAL EVOLUTION; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84934792163     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2015.105     Document Type: Note

References (1)

1. Siravegna, G. et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat. Med. doi:10.1038/nm.3870